Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,405.66 +470.90 (+1.24%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
59,613.41 -3,416.11 (-5.42%) CMC Crypto 200
1,279.39 -59.68 (-4.46%)
Bio-Rad Laboratories, Inc. (BIO)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 277.11 |
| Open | 274.20 |
| Bid | 270.38 x 1200 |
| Ask | 293.00 x 3000 |
| Day's range | 269.05 - 274.74 |
| 52-week range | 261.59 - 473.50 |
| Volume | |
| Avg. volume | 204,711 |
| Market cap | 7.707B |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for
Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
New Strong Sell Stocks for April 19th
ATNI, ABR and BIO have been added to the Zacks Rank #5 (Strong Sell) List on April 19, 2023.
- Zacks
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.
© 2024 Yahoo. All rights reserved.